CMS approves Louisiana's 'Netflix model' with Gilead for hepatitis C drugs

CMS approves Louisiana's 'Netflix model' with Gilead for hepatitis C drugs

Source: 
Biopharma Dive
snippet: 

CMS has approved a Louisiana plan to pay for hepatitis C therapies in Medicaid through supplemental rebate agreements using a Netflix-style subscription model.